Jeffrey Canter, PA
Physician Assistant · Eugene, ORNPI 1124091095
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Redhill Biopharma Inc. at 46.8% of the total. Reporting peaked in 2021 at $3,501 and has fallen 99.3% since, to $23 in 2025. Among physician assistant clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $65.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Redhill Biopharma Inc.$3K
- Medtronic$1K
- Abbott$333
- AbbVie$155
- Si-bone, Inc.$136
- Pfizer$104
- plus $803 from 17 others
What the payments were for
- Speaking & faculty fees$2,28041%
- Travel & lodging$1,14221%
- Food & beverage$2,10338%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Redhill Biopharma Inc. | 12 | $2,583 |
| Medtronic | 13 | $1,410 |
| Abbott | 10 | $333 |
| AbbVie(2 entities) | 8 | $155 |
| Si-bone, Inc. | 1 | $136 |
| Pfizer | 2 | $104 |
| Vertex | 2 | $103 |
| Averitas Pharma Inc. | 2 | $90 |
| Boston Scientific | 6 | $88 |
| Collegium Pharmaceutical, Inc. | 5 | $83 |
| Amgen | 3 | $76 |
| Nalu Medical, Inc. | 4 | $54 |
| Biohaven Pharmaceuticals, Inc. | 2 | $53 |
| IBSA Pharma Inc. | 2 | $44 |
| Forte Bio-pharma LLC | 1 | $40 |
| Scilex Pharmaceuticals Inc. | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Almatica Pharma LLC | 2 | $27 |
| Upsher-smith Laboratories LLC | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $20 |
| Eisai Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOVANTIK$2,539
- SYNCHROMEDII$834
- ETERNA$128
How this compares
$5,524 in reported general payments places this provider in the 95th percentile of 1,756 physician assistant providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 79 | $46,066 |
| Oxycodone Hcl | 684 | $20,646 |
| Xtampza ErOxycodone Myristate | 44 | $19,150 |
| Fentanyl | 193 | $16,774 |
| NucyntaTapentadol Hcl | 13 | $15,920 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 111 | $7,532 |
| Morphine Sulfate ErMorphine Sulfate | 271 | $7,109 |
| Buprenorphine Hcl | 114 | $5,129 |
| Hydromorphone Hcl | 131 | $4,021 |
| Morphine Sulfate | 117 | $3,746 |
| Methadone Hcl | 114 | $3,253 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 112 | $3,161 |
| Naloxone Hcl | 44 | $2,881 |
| Gabapentin | 174 | $2,526 |
| Hydromorphone ErHydromorphone Hcl | 15 | $2,109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta | $83 | $35,06957 claims |
| Upsher-smith Laboratories LLCTopiramate | $24 | $9814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,756 physician assistant providers in Oregon.
Other physician assistant in Eugene
- Devon ParksEugene$62K
- Marissa ReenEugene$15K
- Amanda VansantEugene$12K
- Eduardo ValenzuelaEugene$6K
- Amanda WeinmanEugene$6K
- Cassandra WrenEugene$6K
- Ryan CainCorvallis$55K
- Sean BrownPortland$43K
- Meegan MangumPortland$25K
- Scott FrazeePortland$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.